Naldemedine for treating opioid-induced constipation (TA651)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 September 2020
Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal) (TA468)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 August 2017
Naloxegol for treating opioid‑induced constipation (TA345)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) (TA277)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2013
Prucalopride for the treatment of chronic constipation in women (TA211)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 December 2010
Linaclotide acetate for treating Chronic idiopathic constipation [TS ID 12005]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC